ArticleScientific reports2026
Antiviral activity and chemical characterization of Egyptian Ziziphus spina-christi against human respiratory viruses.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Since acute respiratory infections are the most prevalent illnesses in humans and can develop into respiratory tract infections, they pose a serious threat to public health. One of the most crucial approaches to treating the respiratory tract is development of medications derived from natural sources. Ziziphus spina-christi (L.). is a well-known plant that has been used for centuries in the Middle East to treat a variety of illnesses, such as anti-inflammatory, anti-fungal, anti-microbial, and anti-viral activities. This study examined antiviral properties of Z. spina-christi leaves and fruits against three respiratory viruses: influenza virus H1N1, MERS-CoV, and SARS-CoV-2. The crude methanol extracts of the leaves and fruits were fractionated n-hexane, dichloromethane, and ethyl acetate, along with the remaining aqueous residues of the two parts to give their corresponding fractions. Chemical profiling of the crude extracts and fractions of the leaves and fruits was investigated using LC-ESI-MS/MS analysis. By applying in-silico molecular docking techniques, the compounds identified in the most active extract or fraction were examined to determine which phytocompounds might have antiviral properties and to predict how they function. The results showed that flavonoids, phenolic acids, saponins, sterols, and triterpenes and their glucosides are the major detected compounds in both leaf and fruit fractions and extracts. The most common phenolic in all six samples is caffeic acid, whereas the most common flavonoids in the fruits’ ethyl acetate fraction were quercetin, luteolin, taxifolin, and is quercetin. The common saponin chemicals found in leaf and fruit extracts and their fractions are lotoside II, Ziziphus saponin I, and betulinic acid. The results also exhibited that crude extract of leaves had high antiviral activity against H1N1 with IC50 equal 1.240 µg/ml and against SARS-CoV-2 with IC50 equal 7.397 µg/ml, by performed mode of action the results showed that the extracts had virucidal effect against three viruses by applying in-silico molecular docking techniques, binding energy with HA of H1N1 equal − 7.48 kcal/mol and binding energy with spike of SARS-CoV-2 equal − 10.18 kcal/mol. On the other hand, residual extract had antiviral efficacy against MERS-CoV with an IC50 equal to 1.501 µg/mL and binding energy with the spike equal to -8.19 kcal/mol. Our findings suggest that Z. spina-christi is a natural medication with potent antiviral effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.